Administration of anti‐PD‐L1 antibodies in the tumor model significantly amplified the inhibitory effects of double‐loaded nanoparticles, leading to substantial reductions in tumor weight, volume, and growth rate (Figure 9C–H). This evidence concerns the gene CD274 and neoplasm.